Payment overview · 2025
General Payments
$106.69
6 reported records · 4 companies
Healthcare provider profile · identity verified
Steven E Morton, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · CORBIN, KY · NPI 1932104767
Verified facts
What the public records show
CMS Open Payments records show Steven E Morton, M.D. received $106.69 in general payments during 2025 across 6 reported records.
ABBVIE INC. accounted for 48.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 8 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ARMOUR THYROID as an associated drug or biological on 50 records involving 11 distinct recipient NPIs. Public Medicare Part D data also shows 19 claims for Armour Thyroid by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 126 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 106 claims for Synthroid by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 941 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 24 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $51.82 | 48.6% | 3 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $19.03 | 17.8% | 1 | 2025 |
| Verona Pharma, Inc. | Unresolved — no canonical attribution shown | $18.42 | 17.3% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $17.42 | 16.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $106.69 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $34.50 | 2 | 2025 |
Source payment records
|
|||||
| TEZSPIRE Normalized: tezspire |
Biological | Amgen Inc. | $19.03 | 1 | 2025 |
Source payment records
|
|||||
| Ohtuvayre Normalized: ohtuvayre |
Drug | Verona Pharma, Inc. | $18.42 | 1 | 2025 |
Source payment records
|
|||||
| ABRYSVO Normalized: abrysvo |
Biological | PFIZER INC. | $17.42 | 1 | 2025 |
Source payment records
|
|||||
| COMIRNATY Normalized: comirnaty |
Biological | PFIZER INC. | $17.42 | 1 | 2025 |
Source payment records
|
|||||
| PREVNAR 20 Normalized: prevnar 20 |
Biological | PFIZER INC. | $17.42 | 1 | 2025 |
Source payment records
|
|||||
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $17.32 | 1 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $17.32 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | ARMOUR THYROID open payments reported associated product |
CMS Open Payments — General Payments 50 supporting records · 11 recipient NPIs · example record 1201517088 |
Armour Thyroid · 2024 Exact normalized brand match · 1 Part D row |
19 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
13 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
126 | 29 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
106 | 33 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
941 | 118 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
24 | 23 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 1389 | 376 |
| Pantoprazole Sodium | Pantoprazole Sodium | 1043 | 264 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1038 | 237 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 981 | 304 |
| Levothyroxine Sodium | Levothyroxine Sodium | 980 | 225 |
| Eliquis | Apixaban | 941 | 118 |
| Metoprolol Succinate | Metoprolol Succinate | 898 | 233 |
| Metoprolol Tartrate | Metoprolol Tartrate | 668 | 159 |
| Losartan Potassium | Losartan Potassium | 642 | 178 |
| Valsartan | Valsartan | 531 | 149 |
| Metformin Hcl | Metformin Hcl | 489 | 154 |
| Gabapentin | Gabapentin | 464 | 91 |
| Carvedilol | Carvedilol | 419 | 103 |
| Omeprazole | Omeprazole | 402 | 97 |
| Clopidogrel | Clopidogrel Bisulfate | 357 | 86 |
| Tramadol Hcl | Tramadol Hcl | 340 | 64 |
| Mounjaro | Tirzepatide | 322 | 57 |
| Ozempic | Semaglutide | 315 | 65 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 296 | 106 |
| Tamsulosin Hcl | Tamsulosin Hcl | 285 | 80 |
| Montelukast Sodium | Montelukast Sodium | 277 | 78 |
| Lisinopril | Lisinopril | 267 | 58 |
| Alprazolam | Alprazolam | 258 | 61 |
| Potassium Chloride | Potassium Chloride | 258 | 71 |
| Sertraline Hcl | Sertraline Hcl | 257 | 63 |
| Entresto | Sacubitril/Valsartan | 252 | 36 |
| Lorazepam | Lorazepam | 236 | 38 |
| Glimepiride | Glimepiride | 234 | 69 |
| Simvastatin | Simvastatin | 231 | 58 |
| Furosemide | Furosemide | 230 | 73 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 230 | 54 |
| Jardiance | Empagliflozin | 221 | 50 |
| Tizanidine Hcl | Tizanidine Hcl | 217 | 56 |
| Finasteride | Finasteride | 216 | 66 |
| Donepezil Hcl | Donepezil Hcl | 214 | 38 |
| Fluticasone Propionate | Fluticasone Propionate | 212 | 82 |
| Trazodone Hcl | Trazodone Hcl | 208 | 51 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 204 | 88 |
| Escitalopram Oxalate | Escitalopram Oxalate | 203 | 53 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 201 | 58 |
| Spironolactone | Spironolactone | 196 | 64 |
| Trulicity | Dulaglutide | 194 | 43 |
| Famotidine | Famotidine | 190 | 44 |
| Myrbetriq | Mirabegron | 183 | 25 |
| Alendronate Sodium | Alendronate Sodium | 178 | 39 |
| Duloxetine Hcl | Duloxetine Hcl | 177 | 36 |
| Meloxicam | Meloxicam | 176 | 58 |
| Buspirone Hcl | Buspirone Hcl | 165 | 40 |
| Metformin Hcl Er | Metformin Hcl | 165 | 57 |
| Celecoxib | Celecoxib | 161 | 49 |
| Azithromycin | Azithromycin | 160 | 129 |
| Mirtazapine | Mirtazapine | 158 | 31 |
| Allopurinol | Allopurinol | 157 | 40 |
| Atenolol | Atenolol | 154 | 36 |
| Clonazepam | Clonazepam | 148 | 22 |
| Januvia | Sitagliptin Phosphate | 139 | 30 |
| Hydrochlorothiazide | Hydrochlorothiazide | 136 | 39 |
| Repatha Sureclick | Evolocumab | 135 | 22 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 131 | 100 |
| Linzess | Linaclotide | 126 | 29 |
| Pravastatin Sodium | Pravastatin Sodium | 126 | 36 |
| Memantine Hcl | Memantine Hcl | 124 | 23 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 123 | 32 |
| Ropinirole Hcl | Ropinirole Hcl | 121 | 32 |
| Irbesartan | Irbesartan | 119 | 27 |
| Prednisone | Prednisone | 117 | 56 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 117 | 49 |
| Bumetanide | Bumetanide | 116 | 22 |
| Diclofenac Sodium | Diclofenac Sodium | 115 | 32 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 115 | 39 |
| Ondansetron Hcl | Ondansetron Hcl | 113 | 52 |
| Ondansetron Odt | Ondansetron | 109 | 40 |
| Warfarin Sodium | Warfarin Sodium | 109 | 14 |
| Citalopram Hbr | Citalopram Hydrobromide | 108 | 24 |
| Clonidine Hcl | Clonidine Hcl | 107 | 41 |
| Ventolin Hfa | Albuterol Sulfate | 107 | 31 |
| Propranolol Hcl | Propranolol Hcl | 106 | 23 |
| Synthroid | Levothyroxine Sodium | 106 | 33 |
| Pregabalin | Pregabalin | 105 | 20 |
| Doxycycline Hyclate | Doxycycline Hyclate | 104 | 62 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 104 | 53 |
| Fluoxetine Hcl | Fluoxetine Hcl | 103 | 25 |
| Levofloxacin | Levofloxacin | 102 | 81 |
| Hydralazine Hcl | Hydralazine Hcl | 101 | 36 |
| Quetiapine Fumarate | Quetiapine Fumarate | 101 | 30 |
| Levetiracetam | Levetiracetam | 96 | 18 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 92 | 36 |
| Methylprednisolone | Methylprednisolone | 92 | 75 |
| Mupirocin | Mupirocin | 89 | 46 |
| Nystatin | Nystatin | 89 | 45 |
| Fluconazole | Fluconazole | 88 | 56 |
| Telmisartan | Telmisartan | 88 | 25 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 87 | 26 |
| Ibuprofen | Ibuprofen | 86 | 34 |
| Ranolazine Er | Ranolazine | 86 | 18 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 85 | 62 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 85 | 17 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 85 | 25 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 84 | 66 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 84 | 12 |
| Zolpidem Tartrate | Zolpidem Tartrate | 83 | 16 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 81 | 17 |
| Xarelto | Rivaroxaban | 79 | 12 |
| Baclofen | Baclofen | 78 | 13 |
| Amiodarone Hcl | Amiodarone Hcl | 77 | 11 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 75 | 21 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 75 | 27 |
| Lactulose | Lactulose | 73 | 28 |
| Flecainide Acetate | Flecainide Acetate | 71 | 15 |
| Methocarbamol | Methocarbamol | 70 | 28 |
| Novolog Flexpen | Insulin Aspart | 69 | 28 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 68 | 24 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 66 | 30 |
| Humalog Kwikpen U-100 | Insulin Lispro | 66 | 25 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 65 | 12 |
| Nitroglycerin | Nitroglycerin | 65 | 39 |
| Farxiga | Dapagliflozin Propanediol | 64 | 19 |
| Levemir Flexpen | Insulin Detemir | 64 | 19 |
| Ezetimibe | Ezetimibe | 58 | 21 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 58 | 11 |
| Divalproex Sodium | Divalproex Sodium | 57 | 14 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 55 | 18 |
| Meclizine Hcl | Meclizine Hcl | 52 | 25 |
| Promethazine Hcl | Promethazine Hcl | 52 | 20 |
| Cefdinir | Cefdinir | 51 | 30 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 51 | 41 |
| Lansoprazole | Lansoprazole | 50 | 16 |
| Amitriptyline Hcl | Amitriptyline Hcl | 49 | 16 |
| Glipizide | Glipizide | 49 | 13 |
| Metronidazole | Metronidazole | 49 | 31 |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 49 | 18 |
| Vascepa | Icosapent Ethyl | 49 | 11 |
| Bupropion Xl | Bupropion Hcl | 47 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 47 | 24 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 46 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 46 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 45 | 24 |
| Torsemide | Torsemide | 44 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 43 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 42 | 13 |
| Memantine Hcl Er | Memantine Hcl | 42 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 41 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 41 | 13 |
| Clonidine | Clonidine | 40 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 39 | suppressed |
| Restasis | Cyclosporine | 39 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 38 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 38 | 11 |
| Tradjenta | Linagliptin | 38 | suppressed |
| Latanoprost | Latanoprost | 37 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 37 | 16 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 37 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 36 | 13 |
| Raloxifene Hcl | Raloxifene Hcl | 36 | suppressed |
| Dutasteride | Dutasteride | 35 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 35 | 11 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 33 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 32 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 32 | suppressed |
| Acyclovir | Acyclovir | 31 | 18 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 31 | 14 |
| Rybelsus | Semaglutide | 31 | 13 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 30 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 30 | 11 |
| Naproxen | Naproxen | 30 | suppressed |
| Praluent Pen | Alirocumab | 30 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 30 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 29 | suppressed |
| Estradiol | Estradiol | 29 | 11 |
| Insulin Aspart Flexpen | Insulin Aspart | 29 | suppressed |
| Lamotrigine | Lamotrigine | 29 | suppressed |
| Lidocaine | Lidocaine | 29 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 29 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 29 | suppressed |
| Topamax | Topiramate | 28 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 27 | suppressed |
| Aptiom | Eslicarbazepine Acetate | 27 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 27 | 11 |
| Primidone | Primidone | 27 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 26 | 14 |
| Diazepam | Diazepam | 26 | suppressed |
| Ramipril | Ramipril | 26 | suppressed |
| Aripiprazole | Aripiprazole | 25 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 25 | suppressed |
| Levemir | Insulin Detemir | 25 | suppressed |
| Chlorthalidone | Chlorthalidone | 24 | suppressed |
| Colchicine | Colchicine | 24 | 12 |
| Etodolac | Etodolac | 24 | suppressed |
| Nifedipine Er | Nifedipine | 24 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 24 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 24 | 23 |
| Pioglitazone Hcl | Pioglitazone Hcl | 23 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 23 | suppressed |
| Felodipine Er | Felodipine | 22 | suppressed |
| Anastrozole | Anastrozole | 21 | suppressed |
| Calcitriol | Calcitriol | 21 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 21 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 20 | 13 |
| Doxazosin Mesylate | Doxazosin Mesylate | 20 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 20 | suppressed |
| Humulin R | Insulin Regular, Human | 20 | suppressed |
| Novofine 32 | Pen Needle, Diabetic | 20 | suppressed |
| Amoxicillin | Amoxicillin | 19 | 17 |
| Armour Thyroid | Thyroid,pork | 19 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 19 | suppressed |
| Estradiol (Once Weekly) | Estradiol | 19 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 19 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 19 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 19 | suppressed |
| Rivastigmine | Rivastigmine | 19 | suppressed |
| Sotalol | Sotalol Hcl | 19 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 18 | suppressed |
| Carbamazepine | Carbamazepine | 18 | suppressed |
| Cephalexin | Cephalexin | 18 | 15 |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 18 | suppressed |
| Digoxin | Digoxin | 18 | suppressed |
| Erythromycin | Erythromycin Base | 18 | 16 |
| Hydrocortisone | Hydrocortisone | 18 | 15 |
| Valacyclovir | Valacyclovir Hcl | 18 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 17 | suppressed |
| Folic Acid | Folic Acid | 17 | suppressed |
| Movantik | Naloxegol Oxalate | 17 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 17 | suppressed |
| Cilostazol | Cilostazol | 16 | suppressed |
| Constulose | Lactulose | 16 | 12 |
| Eplerenone | Eplerenone | 16 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 16 | suppressed |
| Lubiprostone | Lubiprostone | 16 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 16 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 16 | suppressed |
| Temazepam | Temazepam | 16 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 16 | suppressed |
| Topiramate | Topiramate | 16 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 15 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 15 | suppressed |
| Fenofibrate | Fenofibrate | 15 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 15 | suppressed |
| Loperamide | Loperamide Hcl | 15 | suppressed |
| Lovastatin | Lovastatin | 15 | suppressed |
| Mexiletine Hcl | Mexiletine Hcl | 15 | suppressed |
| Novolog | Insulin Aspart | 15 | suppressed |
| Brilinta | Ticagrelor | 14 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 14 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 14 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 14 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 14 | suppressed |
| Mirabegron Er | Mirabegron | 14 | suppressed |
| Olanzapine | Olanzapine | 14 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 14 | suppressed |
| Permethrin | Permethrin | 14 | suppressed |
| Repatha Syringe | Evolocumab | 14 | suppressed |
| Terconazole | Terconazole | 14 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 14 | suppressed |
| Verquvo | Vericiguat | 14 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 13 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 13 | 12 |
| Creon | Lipase/Protease/Amylase | 13 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 13 | suppressed |
| Glipizide Er | Glipizide | 13 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 13 | 11 |
| Pilocarpine Hcl | Pilocarpine Hcl | 13 | suppressed |
| Timolol Maleate | Timolol Maleate | 13 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 12 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 12 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 12 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Xifaxan | Rifaximin | 12 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 11 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 11 | suppressed |
| Nyamyc | Nystatin | 11 | suppressed |
| Rexulti | Brexpiprazole | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $106.69 · 6 records | ABBVIE INC. | ABRYSVO, COMIRNATY, Ohtuvayre, PREVNAR 20, QULIPTA, TEZSPIRE, UBRELVY, VRAYLAR | 6 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error